Literature DB >> 12082189

Conventional versus direct stenting in AMI: effect on immediate coronary blood flow.

Timur Timurkaynak1, Murat Ozdemir, Atiye Cengel, Mustafa Cemri, Haci Ciftci, Ridvan Yalcin, Bulent Boyaci, Ovsev Dortlemez, Halis Dortlemez.   

Abstract

There are no data regarding the potential benefits of direct stenting in the setting of AMI. The aim of this study was to evaluate the impact of direct stenting on the angiographic results and compare it to conventional stenting performed in the setting of AMI. We reviewed our institutional interventional database and identified 44 patients who had undergone stenting in the setting of AMI (29 primary and 15 rescue angioplasty). Patients were then divided into two groups; group A consisted of patients who had undergone conventional stenting (23 patients) and group B those who had undergone direct stenting (21 patients). Angiographic success was defined as TIMI flow grade 2. The baseline TIMI 0-1 flow was higher in group A compared to group B (74% vs. 24%; p < 0.05). TIMI flow rates before stenting (after balloon predilation in group A and after guidewire crossing in group B) and angiographic success (TIMI flow 2) after stenting were similar in both groups (p > 0.05). However, the final TIMI 3 flow were significantly better in group B after stenting (65% vs. 95%; p < 0.05). Although there was no no re-flow in group B, three patients in group A had no re-flow after balloon predilatation of lesions with baseline TIMI 2 flow. There was a statistical tendency to a higher TIMI 3 flow in patients treated with direct stenting in the setting of AMI. Direct stenting strategy in thrombus containing lesions seems to be a safe and feasible approach in avoiding no re-flow.

Entities:  

Mesh:

Year:  2002        PMID: 12082189

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  1 in total

Review 1.  Double right coronary artery: review of literature.

Authors:  Hulya Erbagci; Vedat Davutoglu; Serdar Turkmen; Nese Kizilkan; Erdem Gumusburun
Journal:  Int J Cardiovasc Imaging       Date:  2005-12-12       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.